Arctic Vision Ltd. (Biotechnology, Health Care) — Funding, Investors & Signals 2026

Arctic Vision Ltd.

Dual-Engine Powered Innovation Pioneer in Ophthalmology

Founded 2019 China

Shanghai, China 32 employees Series B Total: $132.00M Biotechnology, Health Care +1

Arctic Vision Ltd. is a China-based ophthalmic biotech startup, founded in 2019, with a focus on breakthrough therapies in the field. The company's slogan "Dual-Engine Powered Innovation Pioneer in Ophthalmology" reflects its commitment to leveraging cutting-edge technology and consumer-oriented approaches to bring meaningful and game-changing innovations in ophthalmology. Arctic Vision's last investment of $100.00M in Series B at 09 March 2021 attracted significant attention from prominent investors such as Morningside Ventures, Loyal Valley Capital, Nan Fung Life Sciences, Octagon Capital Advisors, Pivotal bioVenture Partners China, Tencent, and Adrian Cheng, indicating strong support and confidence in the company's potential in the industry. The company's dedication to understanding end-user insights and unlocking ophthalmic innovations is supported by its elite team of ophthalmic industry veterans, with proven track records in research, development, and commercialization of eye care products. Additionally, Arctic Vision is backed by recognized life science investors and biotechnology venture capital with broad networks in China, Asia, the United States, and Europe, providing the company with valuable industry knowledge and experience in business incubation. Arctic Vision's aspirations to access the Chinese market and drive long-term strategic clinical development and growth position it as a trusted partner for global biopharmaceutical companies. The company's dual-engine growth strategy, as well as its commitment to pushing the boundaries of exploration and innovation, demonstrates its dedication to improving vision for mankind and bringing about positive change. In summary, Arctic Vision is well-positioned in the biotechnology and healthcare industries, particularly within the ophthalmic sector. With significant investments and strong industry connections, the company showcases great promise in delivering impactful ophthalmic innovations globally.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	••••••	8	•••• ••••	09 Mar 2021
Series A	••••••	2	•••• ••••	13 Jul 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

••••••

•••• ••••

09 Mar 2021

Series A

••••••

•••• ••••

13 Jul 2020

FAQ About Arctic Vision Ltd.

Dual-Engine Powered Innovation Pioneer in Ophthalmology

Arctic Vision Ltd. was founded in 2019.

Arctic Vision Ltd. is headquartered in Shanghai, China.

Arctic Vision Ltd. operates in the following industries: Biotechnology, Health Care, Life Sciences.

Arctic Vision Ltd. has approximately 32 employees.

Arctic Vision Ltd. has completed 2 funding rounds, raising a total of $132.00M. The latest funding stage is Series B.

Top alternatives and competitors to Arctic Vision Ltd. include RemeGen荣昌生物, Clerio Vision, Inc., Ablaze Pharmaceuticals , Q3 Medical Group, Bioplus Life Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Arctic Vision Ltd. and RemeGen荣昌生物 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Arctic Vision Ltd.

General Information

Track Arctic Vision Ltd.

Discover More

About Arctic Vision Ltd.

Funding Rounds & Investors (2)

Arctic Vision Ltd. Alternatives & Competitors

FAQ About Arctic Vision Ltd.

Don't just browse. Track.